Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)








Study Syllabus for Classification of Radiographs of Pneumoconioses						Print
																Related Pages
										Clinical OverviewMajor Occupational Lung DiseasesPneumoconioses
Silicosis
Silicosis refers to a spectrum of lung diseases caused by inhalation of free crystalline silica. Workers from a broad range of industries are exposed to crystalline silica, with some of the more common industries including coal and hard rock mining, hydraulic fracturing, foundries, tunneling, stone and countertop cutting, sandblasting, construction and masonry, glass manufacturing, concrete and ceramics production, and agriculture.
Several clinical presentations of the disease have been described. Acute silicosis, also known as silicoproteinosis, results from exposure to high concentrations of respirable silica, with symptoms occurring within weeks to a few years after exposure onset. The diagnosis of acute silicosis is based on a history of acute, high-dose silica exposure; imaging findings may include diffuse nodular opacities (Fig. 1) as well as ground glass and patchy consolidative opacities; a milky lipoproteinaceous bronchoalveolar lavage effluent; and exclusion of other potential explanations (e.g., infection, pulmonary edema, alveolar hemorrhage). Accelerated silicosis is also associated with high-level exposure to respirable silica and develops within 10 years. Chronic simple silicosis is characterized radiographically by small rounded opacities (Fig. 2) composed pathologically of hyalinized collagenous nodules. Chest radiograph with detail view (Fig. 2) shows extensive p/q opacities. CT shows primarily centrilobular distribution of nodules characterized by relative uniformity of nodule size, spacing, and sparing of the immediate subpleural area. Chronic complicated silicosis, or progressive massive fibrosis (PMF), is characterized by nodular lung lesions of one centimeter or greater in diameter, usually in the upper lung zones on chest radiograph and CT (Fig. 3). Depending on the stage and severity of disease, resting lung function abnormalities may include reduced lung volumes and diffusion capacity.
Excessive silica exposure is associated with an increased risk for lung cancer, autoimmune disorders (including rheumatoid arthritis, systemic sclerosis and increased serum autoantibodies), chronic kidney disease, chronic airflow obstruction (including emphysema and chronic bronchitis), and lung infections from mycobacteria and some fungal species.
There is no specific treatment sub-acute or chronic. Lung transplantation may be an option for patients with progressive respiratory failure. Medical management is targeted towards controlling ongoing exposure, bronchodilators if airflow limitation is present, monitoring and treatment of infection, pulmonary rehabilitation, supplemental oxygen if hypoxia is present, appropriate vaccinations, and smoking cessation if applicable.
Silicosis, like all of the occupational pneumoconioses, is a preventable disease. Primary prevention through monitoring exposures and maintaining effective controls must be the highest priority. Respiratory protection programs may provide temporary protection of workers but are not a long-term solution to controlling dust levels. Medical monitoring of at-risk workers using chest radiographs and spirometry may help with early detection of those at risk for worsening lung disease with ongoing exposure.CLINICAL INTRODUCTIONPage 1 of 6COAL MINE DUST LUNG DISEASE
							
					
							Last Reviewed:  April 26, 2023						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeStudy Syllabus for Classification of Radiographs of Pneumoconioses
Introductionplus icon
Preface
Appreciation to Contributors
Intent of the Self-study Syllbus
Getting Started
Clinical Overviewplus icon
Major Occupational Lung Diseasesplus icon
Pneumoconioses
Central Role of Diagnostic Imagingplus icon
Role of CT
Overview of Nonimaging Clinical Tools in Lung Disease Diagnosis
Appendix A
References
Pathology Overviewplus icon
Pulmonary Silicosis
Coal Workers’ Pneumoconiosis
Asbestos Pleuropulmonary Disease
Pathological-Clinical Correlations
References
Radiograph Classificationplus icon
SUBSET 1 – Radiograph Classification, #1 to #19plus icon
Introduction
Radiograph Identification
Section 1: Image Quality
Section 2: Parenchymal Abnormalities, #1 to #14
Section 3: Pleural Abnormalities, #15 to #19
Section 4: Any Other Abnormalities
Section 5
SUBSET 2 – Radiograph #20 to #27plus icon
Radiograph #20
Radiograph #21
Radiograph #22
Radiograph #23
Radiograph #24
Radiographs #25 to #27
SUBSET 3 – Radiograph #28 to #38plus icon
Radiographs #28 to #30
Radiographs #31 to #32
Radiographs #33 to #35
Radiographs #36 to #38
SUBSET 4 – Radiograph #39 to #46 (Small and Large Opacities)plus icon
Radiographs #39 to #40
Radiographs #41 to #42
Radiographs #43 to #44
Radiograph #45
Radiograph #46
SUBSET 5 – Classifications and Answer Keys, Radiographs #47 to #83
Quiz Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue